Xu, L., Yu, S., Liu, H., Yi, B., Wang, G., & Liu, Y. (2022). Physiologically based pharmacokinetic combined BTK occupancy modeling for optimal dosing regimen prediction of acalabrutinib in patients alone, with different CYP3A4 variants, co-administered with CYP3A4 modulators and with hepatic impairment. European Journal of Clinical Pharmacology, 78(9), 1435-1447.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Xu, Lifang, Shuang Yu, Huining Liu, Bowen Yi, Guopeng Wang, y Yang Liu. "Physiologically Based Pharmacokinetic Combined BTK Occupancy Modeling for Optimal Dosing Regimen Prediction of Acalabrutinib in Patients Alone, with Different CYP3A4 Variants, Co-administered with CYP3A4 Modulators and with Hepatic Impairment."
European Journal of Clinical Pharmacology 78, no. 9 (2022): 1435-1447.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Xu, Lifang, et al. "Physiologically Based Pharmacokinetic Combined BTK Occupancy Modeling for Optimal Dosing Regimen Prediction of Acalabrutinib in Patients Alone, with Different CYP3A4 Variants, Co-administered with CYP3A4 Modulators and with Hepatic Impairment."
European Journal of Clinical Pharmacology, vol. 78, no. 9, 2022, pp. 1435-1447.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.